Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Advances in Chronic Kidney Disease
|
December 12, 2018
Leadership in the Industry Arena: Nephrologists in Nonclinical Leadership Roles
Akhtar Ashfaq
Expert Opinion on Pharmacotherapy
|
October 6, 2006
Emerging strategies for lowering serum phosphorous in patients with end-stage renal disease
Akhtar Ashfaq, Michael Gitman, Pravin C Singhal
BMC Nephrology
|
May 21, 2011
Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis
Irfan Khan, Mahesh Krishnan, Anupam Kothawala, et al.
Kidney Diseases (Basel, Switzerland)
|
July 27, 2023
Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease
Stephen A Strugnell, Philipp Csomor, Akhtar Ashfaq, et al.
Journal of Medical Economics
|
November 16, 2019
The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3-4 CKD
Kamyar Kalantar-Zadeh, Christopher S Hollenbeak, Roy Arguello, et al.
Forum for Health Economics & Policy
|
March 6, 2020
Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis
Sophie Snyder, Christopher S Hollenbeak, Kamyar Kalantar-Zadeh, et al.
American Journal of Nephrology
|
May 13, 2022
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism
Charles W Bishop, Stephen A Strugnell, Philipp Csomor, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 14, 2025
Effect of race, gender and age on intrinsic diurnal variation of serum calcifediol: Insights into vitamin D toxicity
Charles W Bishop, John Choe, Stephen A Strugnell, et al.
American Journal of Nephrology
|
March 18, 2019
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease
Stephen A Strugnell, Stuart M Sprague, Akhtar Ashfaq, et al.
Kidney International Reports
|
April 29, 2021
Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
James B Wetmore, Yuanyuan Ji, Akhtar Ashfaq, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Advances in Chronic Kidney Disease
|
December 12, 2018
Leadership in the Industry Arena: Nephrologists in Nonclinical Leadership Roles
Akhtar Ashfaq
Expert Opinion on Pharmacotherapy
|
October 6, 2006
Emerging strategies for lowering serum phosphorous in patients with end-stage renal disease
Akhtar Ashfaq, Michael Gitman, Pravin C Singhal
BMC Nephrology
|
May 21, 2011
Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis
Irfan Khan, Mahesh Krishnan, Anupam Kothawala, et al.
Kidney Diseases (Basel, Switzerland)
|
July 27, 2023
Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease
Stephen A Strugnell, Philipp Csomor, Akhtar Ashfaq, et al.
Journal of Medical Economics
|
November 16, 2019
The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3-4 CKD
Kamyar Kalantar-Zadeh, Christopher S Hollenbeak, Roy Arguello, et al.
Forum for Health Economics & Policy
|
March 6, 2020
Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis
Sophie Snyder, Christopher S Hollenbeak, Kamyar Kalantar-Zadeh, et al.
American Journal of Nephrology
|
May 13, 2022
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism
Charles W Bishop, Stephen A Strugnell, Philipp Csomor, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 14, 2025
Effect of race, gender and age on intrinsic diurnal variation of serum calcifediol: Insights into vitamin D toxicity
Charles W Bishop, John Choe, Stephen A Strugnell, et al.
American Journal of Nephrology
|
March 18, 2019
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease
Stephen A Strugnell, Stuart M Sprague, Akhtar Ashfaq, et al.
Kidney International Reports
|
April 29, 2021
Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
James B Wetmore, Yuanyuan Ji, Akhtar Ashfaq, et al.
Page
of 3